Temporal changes in incidence, treatment strategies and 1-year re-admission rates in patients with atrial fibrillation/flutter under 65 years of age: A Danish nationwide study.

[1]  A. Verma,et al.  Progression of Atrial Fibrillation after Cryoablation or Drug Therapy. , 2022, The New England journal of medicine.

[2]  C. Macintyre,et al.  Association of Left Atrial Metrics with Atrial Fibrillation Rehospitalization and Adverse Cardiovascular Outcomes in Patients with Non-valvular Atrial Fibrillation following Index Hospitalization. , 2021, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[3]  G. Breithardt,et al.  Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.

[4]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[5]  E. Hylek,et al.  Trends in Atrial Fibrillation Incidence Rates Within an Integrated Health Care Delivery System, 2006 to 2018 , 2020, JAMA network open.

[6]  E. Benjamin,et al.  Epidemiology of Atrial Fibrillation in the 21st Century , 2020, Circulation research.

[7]  P. Zimetbaum,et al.  Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study , 2020, BMC Cardiovascular Disorders.

[8]  Sigrun Alba Johannesdottir Schmidt,et al.  The Danish health care system and epidemiological research: from health care contacts to database records , 2019, Clinical epidemiology.

[9]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[10]  D. Fitzmaurice,et al.  Temporal trends in antithrombotic treatment of real-world UK patients with newly diagnosed atrial fibrillation: findings from the GARFIELD-AF registry , 2018, BMJ Open.

[11]  M. Chung,et al.  2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2017, Heart rhythm.

[12]  C. Sindet-Pedersen,et al.  Increased use of oral anticoagulants in patients with atrial fibrillation: temporal trends from 2005 to 2015 in Denmark , 2017, European heart journal.

[13]  H. Krumholz,et al.  National Trends in Atrial Fibrillation Hospitalization, Readmission, and Mortality for Medicare Beneficiaries, 1999–2013 , 2017, Circulation.

[14]  H. Bøtker,et al.  Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study , 2016, BMJ Open.

[15]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[16]  Gregory Y. H. Lip,et al.  Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark , 2016, Scientific Reports.

[17]  Sudha Seshadri,et al.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study , 2015, The Lancet.

[18]  L. Køber,et al.  Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[20]  M. Zoni-Berisso,et al.  Epidemiology of atrial fibrillation: European perspective , 2014, Clinical epidemiology.

[21]  J. Tu,et al.  Temporal trends in medication use and outcomes in atrial fibrillation. , 2013, The Canadian journal of cardiology.

[22]  K. Dibb,et al.  Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review , 2013, Cardiology research and practice.

[23]  X. Viñolas,et al.  Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice , 2012, BMC Cardiovascular Disorders.

[24]  K. Overvad,et al.  Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry , 2012, Scandinavian cardiovascular journal : SCJ.

[25]  Stanley Nattel,et al.  Atrial fibrillation pathophysiology: implications for management. , 2011, Circulation.

[26]  J. Hallas,et al.  The Danish National Prescription Registry , 2011, Scandinavian journal of public health.

[27]  C. Pedersen,et al.  The Danish Civil Registration System , 2011, Scandinavian journal of public health.

[28]  Elsebeth Lynge,et al.  The Danish National Patient Register , 2011, Scandinavian journal of public health.

[29]  J. Tolstrup,et al.  Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study , 2011, BMJ : British Medical Journal.

[30]  Margaret C Fang,et al.  Trends in catheter ablation for atrial fibrillation in the United States. , 2009, Journal of hospital medicine.

[31]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[32]  A Laupacis,et al.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. , 1995, Archives of internal medicine.

[33]  Hugh Calkins,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2014, Journal of the American College of Cardiology.

[34]  Christopher X. Wong,et al.  Ten-year trends in the use of catheter ablation for treatment of atrial fibrillation vs. the use of coronary intervention for the treatment of ischaemic heart disease in Australia. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.